0001225208-24-003054.txt : 20240227 0001225208-24-003054.hdr.sgml : 20240227 20240227134641 ACCESSION NUMBER: 0001225208-24-003054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAHNI PAYAL CENTRAL INDEX KEY: 0001817124 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24684954 MAIL ADDRESS: STREET 1: ATTN: PFIZER CORP. SECRETARY STREET 2: 235 EAST 42ND ST. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0508 4 2024-02-23 0000078003 PFIZER INC PFE 0001817124 SAHNI PAYAL 66 HUDSON BOULEVARD EAST ATTN: CORPORATE SECRETARY NEW YORK NY 10001-2192 1 Executive Vice President 0 Common Stock 2024-02-23 4 M 0 11527.0000 27.3400 A 34604.0000 D Common Stock 2024-02-23 4 F 0 905.0000 27.7600 D 33699.0000 D Common Stock 2024-02-23 4 F 0 9314.0000 27.3700 D 24385.0000 D Common Stock 11405.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 27.3400 2024-02-23 4 M 0 11527.0000 0.0000 D 2024-02-23 2024-02-23 Common Stock 11527.0000 0.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Susan E. Grant, by power of atty., for Payal Sahni 2024-02-27